124 related articles for article (PubMed ID: 1453108)
1. Effects of angiotensin-converting enzyme inhibition in diabetic rats with reduced renal function.
Geiger H; Bahner U; Vaaben W; Dammrich J; Heidland A; Luft FC
J Lab Clin Med; 1992 Dec; 120(6):861-8. PubMed ID: 1453108
[TBL] [Abstract][Full Text] [Related]
2. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
Jackson B; Cubela R; Debrevi L; Whitty M; Johnston CI
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S167-9. PubMed ID: 2455124
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
Perico N; Amuchastegui CS; Malanchini B; Bertani T; Remuzzi G
Exp Nephrol; 1994; 2(4):220-8. PubMed ID: 8069658
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibition in experimental in-situ immune complex glomerulonephritis: influence on renal function, proteinuria, and morphology.
Thaiss F; Haas C; Helmchen U; Wenzel U; Stahl RA
Nephrol Dial Transplant; 1996 Jan; 11(1):40-6. PubMed ID: 8649651
[TBL] [Abstract][Full Text] [Related]
5. Diabetic nephropathy in the rat: differing renal effects of an angiotensin converting enzyme inhibitor and a calcium inhibitor.
Whitty MR; Jackson B
Diabetes Res; 1988 Jun; 8(2):91-6. PubMed ID: 2852570
[TBL] [Abstract][Full Text] [Related]
6. Measurement of changes in glomerular filtration rate induced by atrial natriuretic peptide in the rat kidney.
Caron N; Kramp R
Exp Physiol; 1999 Jul; 84(4):689-96. PubMed ID: 10481226
[TBL] [Abstract][Full Text] [Related]
7. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
[TBL] [Abstract][Full Text] [Related]
8. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
[TBL] [Abstract][Full Text] [Related]
9. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction.
Woodman OL; Malakul W; Cao AH; Xu Q; Ritchie RH
Life Sci; 2008 Apr; 82(15-16):847-54. PubMed ID: 18302965
[TBL] [Abstract][Full Text] [Related]
11. Alterations in atrial natriuretic peptide and its receptor levels in long-term, streptozotocin-induced, diabetes in rats.
Obineche E; Chandranath I; Adeghate E; Benedict S; Fahim M; Adem A
Ann N Y Acad Sci; 2006 Nov; 1084():223-34. PubMed ID: 17151304
[TBL] [Abstract][Full Text] [Related]
12. Antagonist for atrial natriuretic peptide receptors ameliorates glomerular hyperfiltration in diabetic rats.
Kikkawa R; Haneda M; Sakamoto K; Koya D; Shikano T; Nakanishi S; Matsuda Y; Shigeta Y
Biochem Biophys Res Commun; 1993 Jun; 193(2):700-5. PubMed ID: 8390251
[TBL] [Abstract][Full Text] [Related]
13. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
[TBL] [Abstract][Full Text] [Related]
14. [Resistance to hemoconcentration but non hypotensive action of atrial natriuretic peptide in diabetes mellitus induced by streptozocin in the rat].
Valentin JP; Sechi LA; Humphreys MH
Arch Mal Coeur Vaiss; 1994 Aug; 87(8):1119-23. PubMed ID: 7755472
[TBL] [Abstract][Full Text] [Related]
15. Effect of aspirin on experimental diabetic nephropathy.
Moel DI; Safirstein RL; McEvoy RC; Hsueh W
J Lab Clin Med; 1987 Sep; 110(3):300-7. PubMed ID: 3475395
[TBL] [Abstract][Full Text] [Related]
16. Effect of angiotensin-converting enzyme inhibition on skeletal muscle oxidative function and exercise capacity in streptozotocin-induced diabetic rats.
Rouyer O; Zoll J; Daussin F; Damgé C; Helms P; Talha S; Rasseneur L; Piquard F; Geny B
Exp Physiol; 2007 Nov; 92(6):1047-56. PubMed ID: 17675412
[TBL] [Abstract][Full Text] [Related]
17. C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats.
Samnegård B; Jacobson SH; Johansson BL; Ekberg K; Isaksson B; Wahren J; Sjöquist M
Nephrol Dial Transplant; 2004 Jun; 19(6):1385-91. PubMed ID: 15004258
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic implications of converting-enzyme inhibitors in renal disease.
Anderson S; Brenner BM
Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):81-7. PubMed ID: 3037894
[TBL] [Abstract][Full Text] [Related]
19. Renal haemodynamics and function in weanling rats treated with enalapril from birth.
Guron G
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):865-70. PubMed ID: 16173949
[TBL] [Abstract][Full Text] [Related]
20. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Vora JP; Oyama TT; Thompson MM; Anderson S
Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
